Skip to main content
NewslettersWatchlist

Entheon Biomedical Corp(ENBI-CN)
CSE

Today's Change
Delayed Last Update
Day Low0.1300
Day High0.1350
Open:0.1300
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Investor Brand Network
Cybin (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate CYB004 Clinical Program
Investor Brand Network
Cybin (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study
Business Wire
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical
Business Wire
Cybin Acquires DMT Clinical Study from Entheon Biomedical
Globe Newswire
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research
Baystreet
Stocks in play: Entheon Biomedical Corp.
Investor Brand Network
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) Featured in Virtual Coverage of Benzinga’s Small Cap Conference
Globe NewsWire
Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics

Profile

Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.